Immunopeptidomics reveals determinants of Mycobacterium tuberculosis antigen presentation on MHC class IOwen Leddy, Bryan D. Bryson, Forest M. White|eLife|2023Cited by 54
MEK inhibition enhances presentation of targetable MHC-I tumor antigens in mutant melanomasLauren Stopfer, Forest M. White, Joshua M. Mesfin et al.|Proceedings of the National Academy of Sciences|2022Cited by 38
Leveraging Immunopeptidomics To Study and Combat Infectious DiseaseOwen Leddy, Bryan D. Bryson, Forest M. White|mSystems|2021Cited by 22
Validation and quantification of peptide antigens presented on MHCs using SureQuantOwen Leddy, Forest M. White, Yufei Cui et al.|Nature Protocols|2024Cited by 11
Immunopeptidomics can inform the design of mRNA vaccines for the delivery of <i>Mycobacterium tuberculosis</i> MHC class II antigensOwen Leddy, Bryan D. Bryson, Paul Ogongo et al.|Science Translational Medicine|2025Cited by 9